ORCHESTRA BIOMED HOLDINGS IN (OBIO)
US68572M1062 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | 1.75M | 2.03M | |||
| Cash Equivalents | 25.61M | 30.56M | 19.78M | 9.94M | 20.34M | |||
| Marketable Securities | 41.32M | 57.04M | 64.00M | 960.00K | 15.45M | |||
| Receivables | 115.00K | 99.00K | 100.00K | 120.00K | 170.00K | |||
| Inventories | 234.00K | 146.00K | 280.00K | 70.00K | 70.00K | |||
| Other Current Assets | 1.28M | 1.27M | 530.00K | 230.00K | 230.00K | |||
| Total Current Assets | 68.55M | 89.11M | 84.69M | 11.32M | 36.25M | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.97M | 2.83M | 3.68M | 1.12M | 1.03M | |||
| Investments And Advances | 2.50M | 2.50M | 2.50M | 400.00K | 190.00K | |||
| Other Non-Current Assets | 1.30M | 769.00K | 4.71M | 690.00K | 630.00K | |||
| Total Non-Current Assets | 6.77M | 6.10M | 10.88M | 2.21M | 1.84M | |||
| TOTAL ASSETS | 75.32M | 95.21M | 95.57M | 13.53M | 38.09M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 0.00 | 2.00M | 4.00M | |||
| Accrued Expenses | 7.43M | 5.80M | 6.07M | 1.89M | 1.44M | |||
| Accounts Payable | 4.72M | 2.90M | 3.97M | 2.03M | 1.77M | |||
| Other Current Liabilities | 4.07M | 2.51M | 8.53M | 6.32M | 7.15M | |||
| Total Current Liabilities | 16.22M | 11.21M | 18.57M | 12.24M | 14.36M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 9.49M | 3.67M | 5.46M | |||
| Deferred Taxes/Income | N/A | N/A | N/A | 5.60M | 5.60M | |||
| Other Non-Current Liabilities | 12.88M | 15.96M | 14.98M | 17.39M | 15.36M | |||
| Total Non-Current Liabilities | 12.88M | 15.96M | 24.47M | 21.07M | 20.82M | |||
| TOTAL LIABILITIES | 29.10M | 27.17M | 43.04M | 33.31M | 35.18M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -293.72M | -248.85M | -199.73M | -166.13M | -143.11M | |||
| Additional Paid In Capital | 339.84M | 316.90M | 86.35M | 94.89M | 94.57M | |||
| Common Shares | 4.00K | 4.00K | 165.92M | 51.45M | 51.45M | |||
| Other Shareholders' Equity | N/A | N/A | -8.00K | 0.00 | -2.00K | |||
| Shares Outstanding | 37.94M | 35.78M | 31.63M | 31.63M | 31.63M | |||
| Tangible Book Value per Share | 1.22 | 1.90 | -3.58 | -2.25 | -1.53 | |||
| Total Shareholders' Equity | 46.22M | 68.04M | 52.53M | -19.78M | 2.91M | |||
| TOTAL LIABILITIES AND EQUITY | 75.32M | 95.21M | 95.57M | 13.53M | 38.09M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | 0.18 | -0.19 | 1.88 | |||
| Current Ratio | 4.23 | 7.95 | 4.56 | 0.92 | 2.52 | |||
| Return On Assets (ROA) | -76.59% | -51.59% | -37.27% | -170.07% | -56.08% | |||
| Return On Equity (ROE) | -124.81% | -72.19% | -67.81% | N/A | -734.02% | |||
All data in USD , ROIC based on taxRate of 0.21